Woodline Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $45.2M | Sell |
976,360
-315,255
| -24% | -$14.6M | 0.24% | 116 |
|
2025
Q1 | $78.8M | Sell |
1,291,615
-270,007
| -17% | -$16.5M | 0.51% | 29 |
|
2024
Q4 | $88.3M | Buy |
1,561,622
+783,466
| +101% | +$44.3M | 0.6% | 24 |
|
2024
Q3 | $40.3M | Buy |
778,156
+14,984
| +2% | +$775K | 0.34% | 91 |
|
2024
Q2 | $31.7M | Sell |
763,172
-6,082
| -0.8% | -$253K | 0.3% | 101 |
|
2024
Q1 | $41.7M | Buy |
769,254
+156
| +0% | +$8.46K | 0.38% | 72 |
|
2023
Q4 | $39.5M | Buy |
769,098
+531,618
| +224% | +$27.3M | 0.43% | 66 |
|
2023
Q3 | $13.8M | Buy |
237,480
+37,280
| +19% | +$2.16M | 0.16% | 179 |
|
2023
Q2 | $12.8M | Sell |
200,200
-61,413
| -23% | -$3.93M | 0.15% | 176 |
|
2023
Q1 | $18.1M | Buy |
261,613
+2,943
| +1% | +$204K | 0.25% | 115 |
|
2022
Q4 | $18.6M | Sell |
258,670
-9,230
| -3% | -$664K | 0.25% | 119 |
|
2022
Q3 | $19M | Sell |
267,900
-582,280
| -68% | -$41.4M | 0.27% | 108 |
|
2022
Q2 | $65.5M | Buy |
850,180
+454,610
| +115% | +$35M | 1.01% | 8 |
|
2022
Q1 | $28.9M | Hold |
395,570
| – | – | 0.47% | 60 |
|
2021
Q4 | $24.7M | Hold |
395,570
| – | – | 0.35% | 67 |
|
2021
Q3 | $23.4M | Hold |
395,570
| – | – | 0.38% | 69 |
|
2021
Q2 | $26.4M | Sell |
395,570
-211,261
| -35% | -$14.1M | 0.49% | 51 |
|
2021
Q1 | $38.3M | Buy |
+606,831
| New | +$38.3M | 0.85% | 30 |
|
2020
Q4 | – | Sell |
-1,103,742
| Closed | -$66.5M | – | 230 |
|
2020
Q3 | $66.5M | Buy |
+1,103,742
| New | +$66.5M | 2.18% | 7 |
|
2020
Q1 | – | Sell |
-552,945
| Closed | -$35.5M | – | 143 |
|
2019
Q4 | $35.5M | Buy |
+552,945
| New | +$35.5M | 1.45% | 24 |
|